CardioDynamics set to join SonoSite

Article

In a special meeting Aug. 11, shareholders of CardioDynamics approved the company’s merger with hand-carried ultrasound pioneer SonoSite.

CardioDynamics set to join SonoSite
In a special meeting Aug. 11, shareholders of CardioDynamics approved the company’s merger with hand-carried ultrasound pioneer SonoSite. Under the $10 million cash deal, they will receive $1.35 per share, representing a 69% premium over the closing share price on June 8, 2009, the day before the definitive merger agreement was announced. The shareholder vote clears the way for CardioDynamics, which makes the BioZ impedance cardiography technology, to join SonoSite as a wholly owned subsidiary. The technology helps diagnose and assess high blood pressure and ventricular function.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.